| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
62,894,000 |
| Market
Cap: |
2.62(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$22.61 - $51.88 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Celldex Therapeutics is a biopharmaceutical company focused on developing therapeutic monoclonal and bispecific antibodies. Co.'s clinical development programs include: CDX-0159, which is a human monoclonal antibody that specifically binds the receptor tyrosine kinase KIT; CDX-1140, which is a human monoclonal antibody targeted to CD40, a key activator of immune response, which is being studied in a Phase1 study; and CDX-527, which is a bispecific antibody that uses Co.'s proprietary anti-PD-L1 and CD27 human antibodies to couple CD27 co-stimulation with blockade of the PD-L1/PD-1 pathway, for which Co. has initiated a Phase 1 study in advanced solid tumors.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
223,855 |
| Total Sell Value |
$0 |
$0 |
$0 |
$8,358,941 |
| Total People Sold |
0 |
0 |
0 |
6 |
| Total Sell Transactions |
0 |
0 |
0 |
8 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Keilani Taha |
VP Medical & Reg Affairs |
– – – |
2008-01-02 |
4 |
A |
$0.43 |
$213 |
D/D |
500 |
2,000 |
|
- |
|
| Catlin Avery W |
Sr. VP & CFO |
• – – |
2007-07-02 |
4 |
A |
$0.71 |
$353 |
D/D |
500 |
21,500 |
|
- |
|
| Ryan Una S |
President & CEO |
• • – |
2007-07-02 |
4 |
A |
$0.71 |
$353 |
D/D |
500 |
899,213 |
|
- |
|
| Paluck Thomas S |
10% Owner |
– – • |
2007-01-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,332,232 |
|
- |
|
| Paluck Thomas S |
10% Owner |
– – • |
2007-01-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,300,114 |
|
- |
|
| Catlin Avery W |
Sr. VP & CFO |
• – – |
2006-08-16 |
4 |
B |
$1.35 |
$6,750 |
D/D |
5,000 |
21,000 |
2.74 |
- |
|
| Ryan Una S |
President & CEO |
• • – |
2006-08-16 |
4 |
B |
$1.36 |
$41,057 |
D/D |
30,300 |
898,713 |
2.81 |
- |
|
| Ryan Una S |
President & CEO |
• • – |
2006-07-03 |
4 |
A |
$1.37 |
$685 |
D/D |
500 |
868,413 |
|
- |
|
| Keilani Taha |
VP Medical & Reg Affairs |
– – – |
2006-07-03 |
4 |
A |
$1.37 |
$685 |
D/D |
500 |
1,500 |
|
- |
|
| Catlin Avery W |
Sr. VP & CFO |
• – – |
2006-07-03 |
4 |
A |
$1.37 |
$685 |
D/D |
500 |
16,000 |
|
- |
|
| Lipton Karen Shoos |
Director |
– • – |
2006-05-15 |
4 |
OE |
$1.23 |
$4,920 |
D/D |
4,000 |
4,000 |
|
- |
|
| Ryan Una S |
President & CEO |
• • – |
2006-01-03 |
4 |
A |
$1.04 |
$519 |
D/D |
500 |
867,913 |
|
- |
|
| Freeman Paula R |
officerTitle |
– – – |
2006-01-03 |
4 |
A |
$1.04 |
$519 |
D/D |
500 |
2,280 |
|
- |
|
| Catlin Avery W |
Sr. VP & CFO |
• – – |
2005-11-22 |
4 |
OE |
$1.14 |
$5,700 |
D/D |
5,000 |
15,500 |
|
- |
|
| Ryan Una S |
President & CEO |
• • – |
2005-09-21 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
1,067,413 |
|
- |
|
| Keilani Taha |
VP Medical & Reg Affairs |
– – – |
2005-07-01 |
4 |
A |
$0.99 |
$497 |
D/D |
500 |
1,000 |
|
- |
|
| Furlong Michael E |
Sr. Dir. Bus. Development |
• – – |
2005-07-01 |
4 |
A |
$0.99 |
$497 |
D/D |
500 |
1,500 |
|
- |
|
| Catlin Avery W |
Sr. VP & CFO |
• – – |
2005-07-01 |
4 |
A |
$0.99 |
$497 |
D/D |
500 |
10,500 |
|
- |
|
| Keilani Taha |
VP Medical & Reg Affairs |
– – – |
2004-12-31 |
4 |
A |
$1.71 |
$855 |
D/D |
500 |
500 |
|
- |
|
| Nicholson Mary |
Sr. Dir Ops Mfg |
– – – |
2004-12-31 |
4 |
A |
$1.71 |
$855 |
D/D |
500 |
500 |
|
- |
|
| Ryan Una S |
President & CEO |
• • – |
2004-12-31 |
4 |
A |
$1.71 |
$855 |
D/D |
500 |
867,413 |
|
- |
|
| Ryan Una S |
President & CEO |
• • – |
2004-11-05 |
4 |
A |
$0.00 |
$0 |
D/D |
400,000 |
866,913 |
|
- |
|
| Sears Peter A |
Director |
– • – |
2004-09-09 |
4 |
B |
$2.04 |
$20,400 |
D/D |
10,000 |
72,739 |
2.39 |
- |
|
| Ryan Una S |
President & CEO |
• • – |
2004-08-03 |
4 |
B |
$1.84 |
$18,709 |
D/D |
10,000 |
466,913 |
2.81 |
- |
|
| Catlin Avery W |
Sr. VP & CFO |
• – – |
2004-08-03 |
4 |
B |
$1.83 |
$6,388 |
D/D |
3,500 |
10,000 |
2.74 |
- |
|
240 Records found
|
|
Page 9 of 10 |
|
|
0.91 (2.14%) 
